NA Proactive news snapshot: Loop Insights, GR Silver Mining, FSD Pharma, BevCanna Enterprises ...

Loop Insights Inc (CVE:MTRX) (OCTMKTS:VRZPF) said it has signed an agreement to grant Austin-based start-up CasaPerks a non-exclusive license to use various aspects of its technology in return for $1.93 million in a combination of cash and shares. In a separate announcement, the company also said that on Monday September 28 it will begin trading on the OTCQB Venture Market under the symbol RACMF. GR Silver Mining Ltd (CVE:GRSL) (OTCQB:GRSLF) received a boost for its Plomosas silver project in Mexico, saying it had found a new zone of high-grade polymetallic mineralization at the formerly producing Plomosas mine. From channel sampling, a continuous intersection, measuring 15.7 metres (m) was found next to the existing "room and pillar" stope on the 775 RL level at the mine, and out into unmined zones, GR Silver said. Part of that length assayed 5.4m at 1,313 grams per ton (g/t) of silver-equivalent, the firm added, while the 15.7m overall length assayed 416 g/t silver equivalent. FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) announced on Monday that the US Food and Drug Administration (FDA) has authorized the initiation of a Phase 2 study for the use of its lead candidate FSD-201, or anti-inflammatory ultra-micronized-palmitoylethanolamide (PEA), to treat coronavirus (COVID-19) patients. The company said it will start dosing patients in October this year. FSD observed that in some cases of COVID-19, there is an “over-exuberant inflammatory response” that may lead to a cytokine storm and ultimately death. Therefore, it is developing FSD-201 for its anti-inflammatory properties to potentially address the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients. "Commencing a phase 2 clinical trial to treat hospitalized COVID-19 patients is a major milestone achieved by our pharmaceutical team led by Dr Edward Brennan and a huge step forward for FSD Pharma," said CEO Raza Bokhari. BevCanna Enterprises Inc (CSE:BEV) (OTCQB:BVNNF) is “extremely pleased” with its position in the cannabis-infused beverage sector ahead of its US and global expansion plans. In a note to shareholders over the weekend, the Vancouver-based company said it had made significant progress on key objectives like finalizing partnerships and signing new white-label clients. BevCanna recently acquired US e-commerce platform Pure Therapy Products Corp as a vehicle to help the company scale its business into the US and abroad. The firm plans to leverage its direct-to-consumer retail capabilities to market natural health products and BevCanna’s own brands. Binovi Technologies Corp (TSXV:VISN) (OTC:BNVIF) has congratulated the National Hockey League’s (NHL) Dallas Stars on their Western Conference Championship and berth in the Stanley Cup Finals. Nomad Royalty Company Ltd (TSX:NSR) (OTCQX:NSRXF) has closed its previously announced acquisition of private firm Valkyrie Royalty Inc, which owns a net-smelter-return (NSR) royalty on the Moss gold mine in Arizona, USA for total share consideration of around C$7.6-million. Nomad issued over 7.3 million shares to the shareholders of Valkyrie. Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) has named cannabis industry veteran Sameer Kumar as an independent director. Sameer was the former president and chief operating officer (COO) of VIOLA Brands, a lifestyle-based cannabis management services organization (MSO), which was founded by former NBA player Al Harrington. Sameer expanded the brand into five markets, drove operational and sales efficiencies, which led to a doubling of production, a double-digit increase in sales and an expansion of margins, propelling VIOLA to become one of the largest live resin concentrate brands in Colorado and Oregon, by market share, highlighted Australis. Klondike Gold Corp (CVE:KG) (OTCPINK:KDKGF) said it had upsized a previously announced private placing to C$3.8 million and brought in around C$1.55 million from closing the first tranche. The explorer said it aims to use the proceeds of the financing to continue advancing its Yukon properties, as well as for general working capital. In the first tranche, Klondike issued 2,600,702 flow-through units at C$0.30 each, comprising of 2,600,702 common shares which are "flow through" shares for Canadian income tax purposes and 1,300,351 warrants.